 | • レポートコード：MRC2-11QY10827 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は筋萎縮性側索硬化症（ルーゲーリック病）治療のグローバル市場について調査・分析したレポートです。種類別（化学療法、幹細胞治療）市場規模、用途別（病院、診断センター、診療所、小売薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別筋萎縮性側索硬化症（ルーゲーリック病）治療の競争状況、市場シェア ・世界の筋萎縮性側索硬化症（ルーゲーリック病）治療市場：種類別市場規模 2015年-2020年（化学療法、幹細胞治療） ・世界の筋萎縮性側索硬化症（ルーゲーリック病）治療市場：種類別市場規模予測 2021年-2026年（化学療法、幹細胞治療） ・世界の筋萎縮性側索硬化症（ルーゲーリック病）治療市場：用途別市場規模 2015年-2020年（病院、診断センター、診療所、小売薬局） ・世界の筋萎縮性側索硬化症（ルーゲーリック病）治療市場：用途別市場規模予測 2021年-2026年（病院、診断センター、診療所、小売薬局） ・北米の筋萎縮性側索硬化症（ルーゲーリック病）治療市場分析：米国、カナダ ・ヨーロッパの筋萎縮性側索硬化症（ルーゲーリック病）治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの筋萎縮性側索硬化症（ルーゲーリック病）治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の筋萎縮性側索硬化症（ルーゲーリック病）治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの筋萎縮性側索硬化症（ルーゲーリック病）治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：GNT Pharma、Amkor Pharma、Synthetic Biologics、Mitsubishi Tanabe Pharma、Avicena、Sanofi ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Amyotrophic Lateral Sclerosis (ALS) is a neurological disease that affects nerve cells in the brain and spinal cords which controls the activity of voluntary muscles. It is also termed as Lou Gehrig’s disease. There are several causes behind ALS which includes gene mutation, disorganized immune response, chemical imbalance etc. The symptoms for ALS mainly include fasciculation, respiratory problems, muscles weakness and cramps. The mortality rate in the ALS patients in high due to breathing problem.
Increasing in the number of patients affected with ALS is one of the major factor to drive the growth of ALS treatment market. Sporadic and familial are two types of ALS disease, in which sporadic disease is most common disease found with 90–95% of the overall cases in US and the government initiatives to examination the research for rare disease and FDA approvals creates an opportunity for various market players due to which the global market of amyotrophic lateral sclerosis treatment is expected to expand at healthy CAGR during the forecast period. Due to lower prevalence rate, awareness about the disease and low treatment availability hinder the growth of ALS treatment market.
Market Analysis and Insights: Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market
The global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Scope and Market Size
Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
GNT Pharma
Amkor Pharma
Synthetic Biologics
Mitsubishi Tanabe Pharma
Avicena
Sanofi
…
Market segment by Type, the product can be split into
Chemotherapy
Stem Cell Therapy
Market segment by Application, split into
Hospitals
Diagnostic Centres
Clinics
Retail Pharmacies
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue
1.4 Market by Type
1.4.1 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Chemotherapy
1.4.3 Stem Cell Therapy
1.5 Market by Application
1.5.1 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Diagnostic Centres
1.5.4 Clinics
1.5.5 Retail Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Perspective (2015-2026)
2.2 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Growth Trends by Regions
2.2.1 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Players by Market Size
3.1.1 Global Top Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Players by Revenue (2015-2020)
3.1.2 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Concentration Ratio
3.2.1 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue in 2019
3.3 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Key Players Head office and Area Served
3.4 Key Players Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Product Solution and Service
3.5 Date of Enter into Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Historic Market Size by Type (2015-2020)
4.2 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2015-2020)
5.2 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size (2015-2020)
6.2 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Key Players in North America (2019-2020)
6.3 North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2015-2020)
6.4 North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size (2015-2020)
7.2 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Key Players in Europe (2019-2020)
7.3 Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2015-2020)
7.4 Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2015-2020)
8 China
8.1 China Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size (2015-2020)
8.2 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Key Players in China (2019-2020)
8.3 China Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2015-2020)
8.4 China Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size (2015-2020)
9.2 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Key Players in Japan (2019-2020)
9.3 Japan Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2015-2020)
9.4 Japan Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size (2015-2020)
10.2 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2015-2020)
11 India
11.1 India Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size (2015-2020)
11.2 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Key Players in India (2019-2020)
11.3 India Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2015-2020)
11.4 India Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size (2015-2020)
12.2 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2015-2020)
12.4 Central & South America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 GNT Pharma
13.1.1 GNT Pharma Company Details
13.1.2 GNT Pharma Business Overview
13.1.3 GNT Pharma Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Introduction
13.1.4 GNT Pharma Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2015-2020))
13.1.5 GNT Pharma Recent Development
13.2 Amkor Pharma
13.2.1 Amkor Pharma Company Details
13.2.2 Amkor Pharma Business Overview
13.2.3 Amkor Pharma Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Introduction
13.2.4 Amkor Pharma Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2015-2020)
13.2.5 Amkor Pharma Recent Development
13.3 Synthetic Biologics
13.3.1 Synthetic Biologics Company Details
13.3.2 Synthetic Biologics Business Overview
13.3.3 Synthetic Biologics Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Introduction
13.3.4 Synthetic Biologics Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2015-2020)
13.3.5 Synthetic Biologics Recent Development
13.4 Mitsubishi Tanabe Pharma
13.4.1 Mitsubishi Tanabe Pharma Company Details
13.4.2 Mitsubishi Tanabe Pharma Business Overview
13.4.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Introduction
13.4.4 Mitsubishi Tanabe Pharma Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2015-2020)
13.4.5 Mitsubishi Tanabe Pharma Recent Development
13.5 Avicena
13.5.1 Avicena Company Details
13.5.2 Avicena Business Overview
13.5.3 Avicena Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Introduction
13.5.4 Avicena Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2015-2020)
13.5.5 Avicena Recent Development
13.6 Sanofi
13.6.1 Sanofi Company Details
13.6.2 Sanofi Business Overview
13.6.3 Sanofi Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Introduction
13.6.4 Sanofi Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2015-2020)
13.6.5 Sanofi Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue
Table 3. Ranking of Global Top Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Chemotherapy
Table 6. Key Players of Stem Cell Therapy
Table 7. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Regions (2015-2020)
Table 11. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Growth Strategy
Table 17. Main Points Interviewed from Key Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Players
Table 18. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue by Players (2015-2020) (Million US$)
Table 19. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Players (2015-2020)
Table 20. Global Top Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment as of 2019)
Table 21. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Product Solution and Service
Table 24. Date of Enter into Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2015-2020) (Million US$)
Table 27. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size Share by Type (2015-2020)
Table 28. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue Market Share by Type (2021-2026)
Table 29. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size Share by Application (2015-2020)
Table 30. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2015-2020) (Million US$)
Table 31. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size Share by Application (2021-2026)
Table 32. North America Key Players Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share (2019-2020)
Table 34. North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2015-2020) (Million US$)
Table 35. North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Type (2015-2020)
Table 36. North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Application (2015-2020)
Table 38. Europe Key Players Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share (2019-2020)
Table 40. Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Type (2015-2020)
Table 42. Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Application (2015-2020)
Table 44. China Key Players Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue (2019-2020) (Million US$)
Table 45. China Key Players Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share (2019-2020)
Table 46. China Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. China Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Type (2015-2020)
Table 48. China Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. China Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Application (2015-2020)
Table 50. Japan Key Players Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share (2019-2020)
Table 52. Japan Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Type (2015-2020)
Table 54. Japan Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share (2019-2020)
Table 58. Southeast Asia Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Type (2015-2020)
Table 60. Southeast Asia Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Application (2015-2020)
Table 62. India Key Players Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue (2019-2020) (Million US$)
Table 63. India Key Players Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share (2019-2020)
Table 64. India Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. India Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Type (2015-2020)
Table 66. India Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. India Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share (2019-2020)
Table 70. Central & South America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Type (2015-2020)
Table 72. Central & South America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Application (2015-2020)
Table 74. GNT Pharma Company Details
Table 75. GNT Pharma Business Overview
Table 76. GNT Pharma Product
Table 77. GNT Pharma Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2015-2020) (Million US$)
Table 78. GNT Pharma Recent Development
Table 79. Amkor Pharma Company Details
Table 80. Amkor Pharma Business Overview
Table 81. Amkor Pharma Product
Table 82. Amkor Pharma Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2015-2020) (Million US$)
Table 83. Amkor Pharma Recent Development
Table 84. Synthetic Biologics Company Details
Table 85. Synthetic Biologics Business Overview
Table 86. Synthetic Biologics Product
Table 87. Synthetic Biologics Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2015-2020) (Million US$)
Table 88. Synthetic Biologics Recent Development
Table 89. Mitsubishi Tanabe Pharma Company Details
Table 90. Mitsubishi Tanabe Pharma Business Overview
Table 91. Mitsubishi Tanabe Pharma Product
Table 92. Mitsubishi Tanabe Pharma Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2015-2020) (Million US$)
Table 93. Mitsubishi Tanabe Pharma Recent Development
Table 94. Avicena Company Details
Table 95. Avicena Business Overview
Table 96. Avicena Product
Table 97. Avicena Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2015-2020) (Million US$)
Table 98. Avicena Recent Development
Table 99. Sanofi Company Details
Table 100. Sanofi Business Overview
Table 101. Sanofi Product
Table 102. Sanofi Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2015-2020) (Million US$)
Table 103. Sanofi Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Type: 2020 VS 2026
Figure 2. Chemotherapy Features
Figure 3. Stem Cell Therapy Features
Figure 4. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Diagnostic Centres Case Studies
Figure 7. Clinics Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Report Years Considered
Figure 10. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Players in 2019
Figure 15. Global Top Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue in 2019
Figure 17. North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
筋萎縮性側索硬化症（ALS）治療の世界市場（～2026年） Amyotrophic lateral sclerosis is a neurodegenerative disease. ALS affects the nerve cells in the brain and spinal cord that control the voluntary muscles. It is also known as the Lou Gehrig’s disease. Amyotrophic lateral sclerosis can be caused due to various factors such as genetics or environmenta…- 筋萎縮性側索硬化症（ALS）の世界市場（～2026年） Amyotrophic lateral sclerosis (ALS) is a group of rare neurological diseases that mainly involve the nerve cells (neurons) responsible for controlling voluntary muscle movement. Developing medical infrastructure in the emerging economies is expected to drive the growth of Amyotrophic lateral scleros…
- 筋萎縮性側索硬化症（ALS）治療薬の世界市場（～2026年） Amyotrophic lateral sclerosis is a neurodegenerative disease. ALS affects the nerve cells in the brain and spinal cord that control the voluntary muscles. It is also known as the Lou Gehrig’s disease. Amyotrophic lateral sclerosis can be caused due to various factors such as genetics or environmenta…
- 多発性硬化症における幹細胞治療の世界市場（～2026年） Multiple sclerosis is a nervous system disease, triggered by unidentified environmental factors that adversely affects the brain and spinal cord. It damages the myelin sheath that surrounds and protects the nerve cells. Some of the symptoms of the disease includes weakness, numbness, blurred vision,…
- 多発性硬化症治療の世界市場（～2026年） Multiple sclerosis (MS) is a demyelinating disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged. This damage disrupts the ability of parts of the nervous system to communicate, resulting in a range of signs and symptoms, including physical, mental, and somet…